At a glance
ClinicalIndex Comparison RecordN/ACompleted· 106 enrolled
Drug / intervention
Iodine capsule +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Community Salt Testing and Relation of Iodine Intake to Visual Information Processing of Ethiopian Infants
In Brief
A clinical study evaluating Iodine capsule and Iodized Salt for Iodine Deficiency Goiter and Infant Development. Completed, enrolled 106 participants across 1 site.
Detailed Summary
This study evaluated efficacy of iodized salt for mothers and their six-month-old infants' thyroid hormones and visual information processing. Half of the participants received 450 g iodized salt for the household each week, while the other half received 225 ug iodine daily as a potassium iodide capsule.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIodine Deficiency Goiter, Infant Development
CountriesEthiopia
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2013
Primary CompletionJan 2013
Study CompletionAug 2013
First PostedMar 2019
TodayJul 2026
First PostedMar 26, 2019
Enrollment StartJan 2, 2013
Primary CompletionJan 30, 2013
Study CompletionAug 10, 2013
TodayJul 2, 2026
Enrollment to primary: 28 daysPosted 7.3 years ago
Interventions
Iodine capsuledietary
225 µg of iodine daily as a capsule of potassium iodide
Iodized Saltother
450 g iodized salt provided for the household weekly. Salt iodine content was 30 to 40 mg iodine /kg salt as KIO3